Rising Cases of Chikungunya and Dengue in France Signal Potential Epidemic
Table of Contents
As of August 21, 2025, France is experiencing a notable increase in locally transmitted cases of Chikungunya and Dengue fever, raising concerns about a potential nationwide epidemic. Health surveillance data confirms 154 local cases of Chikungunya and 13 of Dengue in mainland France (the “hexagonal territory”). This represents a considerable rise compared to 2024, and the surveillance period continues until November 1st. The spread is largely attributed to the increasing presence of the Aedes albopictus mosquito, commonly known as the tiger mosquito.
The Spread of Arboviruses and the Tiger Mosquito
Chikungunya and Dengue are arboviruses – viruses transmitted by arthropods, in this case, mosquitoes. The aedes albopictus mosquito,originally from Southeast Asia,has become established in many parts of Europe,including France. It is notably efficient at transmitting thes viruses to humans. Centers for Disease Control and Prevention – Dengue and World Health Organization – Chikungunya provide complete information on these diseases.
The mosquito’s range is expanding. While historically concentrated in the south of France – Provence-Alpes-Côte d’Azur, Corsica, Occitanie, and Auvergne-Rhône-Alpes – local cases have now been identified in Grand Est, nouvelle-Aquitaine, and Bourgogne-France Comté. This confirms the tiger mosquito is extending its reach across the country, now present in almost 75% of French departments.
Case Numbers and Trends
The current case numbers represent a significant increase from 2024, where 83 autochthonous (locally acquired) cases of Dengue and 1 case of Chikungunya were confirmed. Approximately forty new Chikungunya cases and two Dengue cases have been added in the latest assessment compared to the previous week. Furthermore, 27 out of 34 identified homes are currently active with mosquito presence, indicating continued transmission risk.
ANSES Warnings and Future Outlook
The French Agency for Food, Environmental and Occupational Health & Safety (ANSES) predicted a high probability of a national epidemic within the next five years in 2024. ANSES The current data strongly supports this forecast. Each year has seen record levels of locally transmitted cases, and the extended surveillance period suggests the risk remains elevated.
Symptoms and Prevention
Chikungunya and Dengue can cause debilitating symptoms.
Chikungunya: Typically causes fever and severe joint pain, which can be chronic. Other symptoms include headache, muscle pain, joint swelling, and rash.
Dengue: Can manifest as a mild flu-like illness or develop into a more severe form, Dengue hemorrhagic Fever (DHF), which can be life-threatening. Symptoms include high fever, severe headache, pain behind the eyes, muscle and joint pain, nausea, vomiting, and rash.
preventive measures are crucial:
Mosquito Bite Prevention: use insect repellent containing DEET, picaridin, or IR3535. Wear long sleeves and pants when outdoors, especially during peak mosquito activity hours (dawn and dusk).
Eliminate Breeding Sites: Mosquitoes breed in standing water. Regularly empty and clean containers that hold water, such as flower pots, tires, and gutters.
Window Screens: Ensure windows and doors have screens to prevent mosquitoes from entering homes.
It is indeed vital to consult a doctor if you suspect you have contracted either Chikungunya or Dengue fever. Early diagnosis and treatment can help manage symptoms and prevent complications.
Disclaimer: This information is for general knowledge and informational purposes only, and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.*